Zhenyou Jiang

Prof. Zhenyou Jiang

Medical College, Jinan University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2018 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
YYYu‐Qi Yan
Yu‐Qi Yan
YFYing‐Jie Fu
Ying‐Jie Fu
SWSha Wu
Sha Wu
HQHong‐Qiong Qin
Hong‐Qiong Qin
XZXiao Zhen
Xiao Zhen
ZJZhenyou Jiang
Zhenyou Jiang

5 December 2019 in Small
Verified
Journal Article
Closed access
PDF file
HXHanhan Xie
Hanhan Xie
MLMingqiang Liu
Mingqiang Liu
BYBaihao You
Baihao You
GLGuanghong Luo
Guanghong Luo
YCYue Chen
Yue Chen
Xue-Feng YuXue-Feng Yu
Xue-Feng Yu

16 March 2012 in Journal of Materials Chemistry
Verified
Journal Article
Closed access
PDF file
JCJianghu Cui
Jianghu Cui
CHChaofan Hu
Chaofan Hu
YYYunhua Yang
Yunhua Yang
YWYongjian Wu
Yongjian Wu
LYLufeng Yang
Lufeng Yang
ZJZhenyou Jiang
Zhenyou Jiang
Carbonaceous nanospheres with silver nanoparticles (CNs-Ag) composites were prepared by a facile and low cost method. Silver nanoparticles were successfully loaded onto the surface of carbonaceous nanospheres, which were examined by X-ray diffraction, UV-vis spectra, transmission electron microscopy, energy dispersive spectrometry and X-ray photoelectron spectroscopy. The antibacterial properties of the CNs-Ag composites were investigated by the kinetics of bacterial growth and a disk-diffusion test. The cytotoxicity of the CNs-Ag composites was determined by MTT assay. The results suggest that the obtained CNs-Ag composites exhibit enhanced antibacterial properties and lower cytotoxicity in comparison with silver nanoparticles. The composites may be alternative antibacterial materials with mild cytotoxicity in biomedical fields.

17 November 2023 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YKYue Kong
Yue Kong
YLYugeng Liu
Yugeng Liu
XLXianzhe Li
Xianzhe Li
MRMenglan Rao
Menglan Rao
DLDawei Li
Dawei Li
QZQiang Zhang
Qiang Zhang
Background: Protein palmitoylation, which is catalyzed by palmitoyl-transferase and de-palmitoyl-transferase, plays a crucial role in various biological processes. However, the landscape and dynamics of protein palmitoylation in human cancers are not well understood. Methods: We utilized 23 palmitoyl-acyltransferases and seven de-palmitoyl-acyltransferases as palmitoylation-related genes for protein palmitoylation analysis. Multiple publicly available datasets were employed to conduct pan-cancer analysis, examining the transcriptome, genomic alterations, clinical outcomes, and correlation with c-Myc (Myc) for palmitoylation-related genes. Real-time quantitative PCR and immunoblotting were performed to assess the expression of palmitoylation-related genes and global protein palmitoylation levels in cancer cells treated with Myc depletion or small molecule inhibitors. Protein docking and drug sensitivity analyses were employed to predict small molecules that target palmitoylation-related genes. Results: We identified associations between palmitoylation and cancer subtype, stage, and patient survival. We discovered that abnormal DNA methylation and oncogenic Myc-driven transcriptional regulation synergistically contribute to the dysregulation of palmitoylation-related genes. This dysregulation of palmitoylation was closely correlated with immune infiltration in the tumor microenvironment and the response to immunotherapy. Importantly, dysregulated palmitoylation was found to modulate canonical cancer-related pathways, thus influencing tumorigenesis. To support our findings, we performed a proof-of-concept experiment showing that depletion of Myc led to reduced expression of most palmitoylation-related genes, resulting in decreased global protein palmitoylation levels. Through mass spectrometry and enrichment analyses, we also identified palmitoyl-acyltransferases ZDHHC7 and ZDHHC23 as significant contributors to mTOR signaling, DNA repair, and immune pathways, highlighting their potential roles in tumorigenesis. Additionally, our study explored the potential of three small molecular (BI-2531, etoposide, and piperlongumine) to modulate palmitoylation by targeting the expression or activity of palmitoylation-related genes or enzymes. Conclusions: Overall, our findings underscore the critical role of dysregulated palmitoylation in tumorigenesis and the response to immunotherapy, mediated through classical cancer-related pathways and immune cell infiltration. Additionally, we propose that the aforementioned three small molecule hold promise as potential therapeutics for modulating palmitoylation, thereby offering novel avenues for cancer therapy.

1 July 2020 in Biochemical Pharmacology
Verified
Journal Article
Closed access
ZCZide Chen
Zide Chen
GXGang Xu
Gang Xu
DWDong Wu
Dong Wu
SWShihai Wu
Shihai Wu
LGLong Gong
Long Gong
XLXianming Li
Xianming Li

20 August 2018 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
YFYingjie Fu
Yingjie Fu
YYYu-Qi Yan
Yu-Qi Yan
HQHong-Qiong Qin
Hong-Qiong Qin
SWSha Wu
Sha Wu
SSShan-Shan Shi
Shan-Shan Shi
ZJZhenyou Jiang
Zhenyou Jiang
Influenza virus is a single-stranded RNA virus that causes influenza in humans and animals. About 600 million people around the world suffer from influenza every year. Upon recognizing viral RNA molecules, TLR7 (Toll-like receptor) initiates corresponding immune responses. Traditional Chinese Medicines (TCMs), including Yinqiao powder, Xinjiaxiangruyin and Guizhi-and-Mahuang decoction, have been extensively applied in clinical treatment of influenza. Although the therapeutic efficacy of TCMs against influenza virus in vivo was reported previously, its underlying mechanisms are not clearly understood. This study aimed to investigate the immunological mechanisms in the treatment of influenza virus infected mice with three Chinese herbal compounds as well as the effect on TLR7/NF-κB signaling pathway during recovery. Wild type and TLR7 KO C57BL/6 mice were infected with influenza virus FM1 and then treated with three TCMs. The physical parameters of mice (body weight and lung index) and the expression levels of components in TLR7/NF-κB signaling pathway were evaluated. After viral infection, Guizhi-and-Mahuang decoction and Yinqiao powder showed better anti-viral effect under normal condition. Compared to the viral control group, expression levels of TLR7, MyD88, IRAK4 and NF-κB were significantly reduced in all treatment groups. Furthermore, the three TCM treatment groups showed poor therapeutic efficacy and no difference in viral load compared to the viral control group in TLR7 KO mice. Our study indicated that Guizhi-and-Mahuang decoction and Yinqiao powder might play a crucial role of anti-influenza virus by regulating TLR7/NF-κB signal pathway.